Jean F. Voltaire

Array ( [id] => 8214448 [patent_doc_number] => 08193238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Inhibition of microtubule protrusion in cancer cells' [patent_app_type] => utility [patent_app_number] => 12/282014 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 29742 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193238.pdf [firstpage_image] =>[orig_patent_app_number] => 12282014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247837 [patent_doc_number] => 20070244071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Treatment of proliferative diseases' [patent_app_type] => utility [patent_app_number] => 11/715193 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18655 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244071.pdf [firstpage_image] =>[orig_patent_app_number] => 11715193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070360 [patent_doc_number] => 20070191462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Combination of A 5-HT(1) Receptor Agonist and an Alpha-2-Delta Ligand for the Treatment of Migraine' [patent_app_type] => utility [patent_app_number] => 11/682040 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14358 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191462.pdf [firstpage_image] =>[orig_patent_app_number] => 11682040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131580 [patent_doc_number] => 20070207977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Naphthalimide compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/676176 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8309 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207977.pdf [firstpage_image] =>[orig_patent_app_number] => 11676176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120710 [patent_doc_number] => 20070142425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Use of CCI-779 as an antineoplastic agent' [patent_app_type] => utility [patent_app_number] => 11/701109 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2879 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142425.pdf [firstpage_image] =>[orig_patent_app_number] => 11701109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6452926 [patent_doc_number] => 20100280412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Anticoagulation Of Human Blood Ex Vivo' [patent_app_type] => utility [patent_app_number] => 12/223280 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12826 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280412.pdf [firstpage_image] =>[orig_patent_app_number] => 12223280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989492 [patent_doc_number] => 20070155833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'OXALIPLATIN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 11/627648 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6794 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155833.pdf [firstpage_image] =>[orig_patent_app_number] => 11627648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253977 [patent_doc_number] => 20070135433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'IMIDAZOLE DERIVATIVES AS RAF KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/625406 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11604 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135433.pdf [firstpage_image] =>[orig_patent_app_number] => 11625406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5178085 [patent_doc_number] => 20070179145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives' [patent_app_type] => utility [patent_app_number] => 11/655801 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6756 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179145.pdf [firstpage_image] =>[orig_patent_app_number] => 11655801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5254049 [patent_doc_number] => 20070135505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Aralkyl ester soft drugs' [patent_app_type] => utility [patent_app_number] => 11/652365 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6744 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135505.pdf [firstpage_image] =>[orig_patent_app_number] => 11652365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177964 [patent_doc_number] => 07655673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => '39-desmethoxyrapamycin, compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/651669 [patent_app_country] => US [patent_app_date] => 2007-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13131 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655673.pdf [firstpage_image] =>[orig_patent_app_number] => 11651669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046637 [patent_doc_number] => 20070265311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Therapeutic Salt Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 11/620626 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2466 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265311.pdf [firstpage_image] =>[orig_patent_app_number] => 11620626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480827 [patent_doc_number] => 20090203784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'TREATMENT REGIMEN FOR N-MYC, C-MYC, AND L-MYC AMPLIFIED AND OVEREXPRESSED TUMORS' [patent_app_type] => utility [patent_app_number] => 12/158661 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14830 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203784.pdf [firstpage_image] =>[orig_patent_app_number] => 12158661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4575340 [patent_doc_number] => 07825137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Method of treating abnormal cell growth' [patent_app_type] => utility [patent_app_number] => 12/095114 [patent_app_country] => US [patent_app_date] => 2006-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17391 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825137.pdf [firstpage_image] =>[orig_patent_app_number] => 12095114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857641 [patent_doc_number] => 08883841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Oncogenic ras-specific cytotoxic compound and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/094739 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 36 [patent_no_of_words] => 37441 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12094739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792785 [patent_doc_number] => 20080293759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Method for Treating Cancer Based on the Modulation of Calcineurin' [patent_app_type] => utility [patent_app_number] => 12/091963 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15643 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293759.pdf [firstpage_image] =>[orig_patent_app_number] => 12091963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543715 [patent_doc_number] => 20100016208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'PHOTOACTIVATABLE ANTIMICROBIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/093510 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15193 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016208.pdf [firstpage_image] =>[orig_patent_app_number] => 12093510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860365 [patent_doc_number] => 20080269215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Bisamide Inhibitors of Hedgehog Signaling' [patent_app_type] => utility [patent_app_number] => 12/093530 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18629 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269215.pdf [firstpage_image] =>[orig_patent_app_number] => 12093530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446084 [patent_doc_number] => 20100144749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/093515 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7046 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144749.pdf [firstpage_image] =>[orig_patent_app_number] => 12093515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515439 [patent_doc_number] => 08039511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Use of isothiocyanates compounds in treating prostatic diseases and skin cancer' [patent_app_type] => utility [patent_app_number] => 12/093829 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 16047 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039511.pdf [firstpage_image] =>[orig_patent_app_number] => 12093829 [rel_patent_id] =>[rel_patent_doc_number] =>)